Mitchell Chan – Biography
Last update: April 9, 2026Executive profile
Mitchell was Director of Investor Relations at AstraZeneca US, and Commercial Finance at Genentech. Mitchell served as Vice President, Head of Finance and Corporate Strategy at Avalo Therapeutics.
Mitchell Chan is currentlyChief Financial Officer at RegenxBio - View - RegenxBio org chart
Director at Avalo Therapeutics - View - Avalo Therapeutics org chart
Create your alert
to follow the career of Mitchell Chan.
Education
Mitchell Chan has a Strategic Finance Executive Program from University of Pennsylvania - The Wharton School and a Venture Capital Executive Program from University of California, Berkeley - HAAS School of Business.
They have also studied at University of Pennsylvania - The Wharton School :
Find more alumni from University of Pennsylvania - The Wharton School
They have also studied at University of California, Berkeley - HAAS School of Business :
Find more alumni from University of California, Berkeley - HAAS School of Business
More about Mitchell Chan
Selected links
Do you need to know more about Mitchell Chan? More results.
Participate
Social media
- Mitchell Chan on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Mitchell Chan
The colleagues of Mitchell Chan
Company Colleagues
- At RegenxBio, Mitchell Chan has 29 colleagues including Curran Simpson (CEO & Director), Jean Bennett (Director)…
- At Avalo Therapeutics, Mitchell Chan has 24 colleagues including Garry Neil (CEO), Kevin Lind (Director)…
Homonyms
- Mitchell Chaney - Partner, Commercial Litigation - McGinnis Lochridge
Industry Colleagues
- In the Biotechnology industry, Mitchell Chan has 35,918 colleagues in 2,415 companies located in 43 countries. 17,045 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Mitchell Chan.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Mitchell Chan.
